Doximity, Inc.
DOCS· NYSE
Released Feb 6, 2025, after the close
10-Q filed Feb 6, 2025, 37 days after period end · 0001516513-25-000012
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Revenue | $168.60M | $135.28M | $115.26M | $97.88M |
| Net Income | $75.20M | $47.96M | $33.47M | $55.65M |
| EPS Diluted |
Doximity, Inc. · CIK 1516513 · Engraved from SEC EDGAR
| $0.37 |
| $0.24 |
| $0.16 |
| $0.26 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.